powered by▸healthparse

Search Cohort Builder

KOL Finder Territories Drug Compare

By state By specialty

Search Cohort Builder Tools KOL Finder Territories Drug Compare AI Query Browse By state By specialty Pricing

PROVIDER PROFILE · NPI 1750389250

Hyma Vempaty

Hematology-OncologyStanford, CAI

CROSS-REFERENCE

Related data on other Healthparse brands

OIG/SAM exclusion screening, sanctions history

© 2026 CareTrace

Pricing Contact Privacy Terms

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

193

Beneficiaries

—

Total drug cost

$904K

Distinct drugs

9

Brand share

31.6%

Top prescribed drugs

Hydroxyurea36 claims

Lenalidomide28 claims

Acyclovir27 claims

Ruxolitinib Phosphate23 claims

Prednisone22 claims